ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 127 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $359,000 | -50.2% | 4,800 | -62.2% | 0.00% | -71.4% |
| Q3 2021 | $721,000 | -32.3% | 12,700 | -47.5% | 0.01% | -30.0% |
| Q2 2021 | $1,065,000 | -10.4% | 24,200 | +0.4% | 0.01% | -16.7% |
| Q1 2021 | $1,189,000 | +56.0% | 24,100 | +33.1% | 0.01% | +50.0% |
| Q4 2020 | $762,000 | +12.4% | 18,100 | +22.3% | 0.01% | 0.0% |
| Q3 2020 | $678,000 | +1.5% | 14,800 | +11.3% | 0.01% | 0.0% |
| Q2 2020 | $668,000 | +8.3% | 13,300 | +10.8% | 0.01% | 0.0% |
| Q1 2020 | $617,000 | -22.0% | 12,000 | -6.2% | 0.01% | -11.1% |
| Q4 2019 | $791,000 | +24.2% | 12,800 | +20.8% | 0.01% | +28.6% |
| Q3 2019 | $637,000 | -23.7% | 10,600 | +7.1% | 0.01% | -30.0% |
| Q2 2019 | $835,000 | -7.0% | 9,900 | +5.3% | 0.01% | -9.1% |
| Q1 2019 | $898,000 | +15.3% | 9,400 | -14.5% | 0.01% | 0.0% |
| Q4 2018 | $779,000 | -7.0% | 11,000 | +12.2% | 0.01% | +10.0% |
| Q3 2018 | $838,000 | +7.9% | 9,800 | +2.1% | 0.01% | +11.1% |
| Q1 2018 | $777,000 | -37.2% | 9,600 | -54.5% | 0.01% | -40.0% |
| Q4 2017 | $1,238,000 | -40.2% | 21,100 | -52.3% | 0.02% | -40.0% |
| Q3 2017 | $2,069,000 | -12.7% | 44,200 | -32.9% | 0.02% | -16.7% |
| Q2 2017 | $2,371,000 | +19.3% | 65,900 | +2.2% | 0.03% | +15.4% |
| Q1 2017 | $1,987,000 | +108.9% | 64,500 | +127.1% | 0.03% | +100.0% |
| Q4 2016 | $951,000 | +1.3% | 28,400 | -19.5% | 0.01% | -7.1% |
| Q3 2016 | $939,000 | +73.9% | 35,300 | +44.1% | 0.01% | +75.0% |
| Q2 2016 | $540,000 | +2.9% | 24,500 | +54.1% | 0.01% | 0.0% |
| Q4 2015 | $525,000 | -48.5% | 15,900 | -43.6% | 0.01% | -50.0% |
| Q3 2015 | $1,019,000 | -20.5% | 28,200 | -1.1% | 0.02% | -15.8% |
| Q2 2015 | $1,282,000 | +224.6% | 28,500 | +120.9% | 0.02% | +216.7% |
| Q1 2015 | $395,000 | – | 12,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
| Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
| ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
| Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
| Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
| Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
| AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
| Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |